ConductScience.org, home

Paper7547697

Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production.

Mingari MC and 6 others. Int Immunol, 1995. Cited by 206 papers, by iCite.

Cite this record

ConductScience Library. Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production. Papers, record 7547697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7547697

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production.
PubMed
Journal
Int Immunol
PubMed
Year
1995
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
206
iCite
Relative citation ratio, by iCite
3.82
iCite
Revised in PubMed
2019-05-12
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mingari MCM C
2Vitale CC
3Cambiaggi AA
4Schiavetti FF
5Melioli GG
6Ferrini SS
7Poggi AA

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, CDMajor topic
Histocompatibility Antigens Class IMajor topic
Killer Cells, NaturalMajor topic
LymphokinesMajor topic
Receptors, Antigen, T-CellMajor topic
Receptors, ImmunologicMajor topic
T-Lymphocytes, CytotoxicMajor topic
Clone Cells
Cytotoxicity Tests, Immunologic
HLA-B Antigens
Humans
Receptors, KIR
Receptors, KIR2DL3

Source PubMed

Download CSV of topics

Cited by44

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 206 citations.

PMIDTitleJournalYearIn PapersSource
42793134NKR-P1A/CD161: A Multifunctional Immune Receptor at the Crossroads of Antitumor Immunity.Biomolecules2026https://conductscience.org/library/papers/42793134PubMed
35036073Innate-like NKp30+CD8+ T cells armed with TCR/CAR target tumor heterogeneity.Oncoimmunology2021https://conductscience.org/library/papers/35036073PubMed
34966390Donor NK and T Cells in the Periphery of Lung Transplant Recipients Contain High Frequencies of Killer Cell Immunoglobulin-Like Receptor-Positive Subsets.Front Immunol2021https://conductscience.org/library/papers/34966390PubMed
34559552Human cytomegalovirus expands a CD8+ T cell population with loss of BCL11B expression and gain of NK cell identity.Sci Immunol2021https://conductscience.org/library/papers/34559552PubMed
34349169Deciphering the biology of KIR2DL3+ T lymphocytes that are associated to relapse in haploidentical HSCT.Sci Rep2021https://conductscience.org/library/papers/34349169PubMed
34153005Cytomegalovirus mediates expansion of IL-15-responsive innate-memory cells with SIV killing function.J Clin Invest2021https://conductscience.org/library/papers/34153005PubMed
33870131Role of NKG2a/c+CD8+ T cells in pathogenic versus non-pathogenic SIV infections.iScience2021https://conductscience.org/library/papers/33870131PubMed
33603738Gamma/Delta T Cells in the Course of Healthy Human Pregnancy: Cytotoxic Potential and the Tendency of CD8 Expression Make CD56+ γδT Cells a Unique Lymphocyte Subset.Front Immunol2020https://conductscience.org/library/papers/33603738PubMed
32335915Inhibitory checkpoints in human natural killer cells: IUPHAR Review 28.Br J Pharmacol2020https://conductscience.org/library/papers/32335915PubMed
32165419Terminally Differentiated Effector Memory CD8+ T Cells Identify Kidney Transplant Recipients at High Risk of Graft Failure.J Am Soc Nephrol2020https://conductscience.org/library/papers/32165419PubMed
31231370Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation.Front Immunol2019https://conductscience.org/library/papers/31231370PubMed
30778167Human NK cells: surface receptors, inhibitory checkpoints, and translational applications.Cell Mol Immunol2019https://conductscience.org/library/papers/30778167PubMed
29895693Distinct human circulating NKp30+FcεRIγ+CD8+ T cell population exhibiting high natural killer-like antitumor potential.Proc Natl Acad Sci U S A2018https://conductscience.org/library/papers/29895693PubMed
20722764The tortoise and the hare: slowly evolving T-cell responses take hastily evolving KIR.Immunology2010https://conductscience.org/library/papers/20722764PubMed
20634877The emerging role of HLA-E-restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumors.J Biomed Biotechnol2010https://conductscience.org/library/papers/20634877PubMed
20067541Priming of immune responses against transporter associated with antigen processing (TAP)-deficient tumours: tumour direct priming.Immunology2009https://conductscience.org/library/papers/20067541PubMed
18706662T-cells expressing natural killer (NK) receptors are altered in multiple sclerosis and responses to alpha-galactosylceramide are impaired.J Neurol Sci2008https://conductscience.org/library/papers/18706662PubMed
16412060NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease.Clin Exp Immunol2006https://conductscience.org/library/papers/16412060PubMed
14562047Functional and molecular characterization of a KIR3DL2/p140 expressing tumor-specific cytotoxic T lymphocyte clone infiltrating a human lung carcinoma.Oncogene2003https://conductscience.org/library/papers/14562047PubMed
12960383HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes.Proc Natl Acad Sci U S A2003https://conductscience.org/library/papers/12960383PubMed

See all 44 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CDK11B984PubTator's text mininghttps://conductscience.org/library/genes/984NCBI Gene
HLA-C3107PubTator's text mininghttps://conductscience.org/library/genes/3107NCBI Gene
KLRD13824PubTator's text mininghttps://conductscience.org/library/genes/3824NCBI Gene
TRBV20OR9-26962PubTator's text mininghttps://conductscience.org/library/genes/6962NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7547697

GET https://conductscience.org/api/papers/v1/7547697/cited_by?page=2